ha14-1 and navitoclax
ha14-1 has been researched along with navitoclax in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bharti, A; Chipuk, JE; Elkholi, R; Renault, TT | 1 |
Other Studies
1 other study(ies) available for ha14-1 and navitoclax
| Article | Year |
|---|---|
B cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins.
Topics: Aniline Compounds; Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Bcl-2-Like Protein 11; bcl-X Protein; Benzamides; Benzopyrans; BH3 Interacting Domain Death Agonist Protein; Biphenyl Compounds; HeLa Cells; Humans; Indoles; Membrane Proteins; Mice; Mitochondria, Liver; Mitochondrial Membranes; Molecular Mimicry; Myeloid Cell Leukemia Sequence 1 Protein; Nitriles; Nitrophenols; Permeability; Piperazines; Protein Interaction Domains and Motifs; Proto-Oncogene Proteins; Pyrroles; Sulfonamides; Sulfones; Unilamellar Liposomes | 2014 |